News Headlines

Study Identifies Single microRNA Biomarker for Prognosis of Mesothelioma Patients
18 February 2010
Demonstrate potential of miR-29c* to act as an independent prognostic factor for time to progression as well as survival after surgery.

Automating Viral RNA Genotyping
18 February 2010
Agilent Automation Solutions has released a new applications bulletin that describes an automated system for rapid characterization of pathogens, including for example the Influenza A (H1N1) virus.

PBL InterferonSource: 20 Years of Interferon Excellence
18 February 2010
Celebrating the 20th anniversary of its expertise in the field of interferons

FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
17 February 2010
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.

MDRNA, Inc. Reports Positive Results for its Proprietary siRNA Delivery Technology
09 February 2010
Data demonstrates the potential for long-term stability of drug products.

Mirrx Therapeutics Secures Seed Financing for Development of microRNA- blocking Technology
09 February 2010
Finances will enable the company to achieve in vivo proof of concept for its microRNA-blocking Blockmir technology.

OGI Announces Genomics Technology Seeding Award to UHN Microarray Centre
08 February 2010
UHN Microarray Centre will receive $10,000 to evaluate several RNA amplification methods to extend the applicability of the nCounterâ„¢ system.

QIAGEN Unit and Pfizer Collaborates to Develop a Companion Diagnostic for Brain Tumor Patients
08 February 2010
Both companies have entered into an agreement to develop a companion diagnostic test kit for PF-04948568.